GLP-2(3-33)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GLP-2(3-33), covering 2025-05-02 to 2025-05-02. Get the full timeline:
Most recent: Clinical Trial Update: Blocking of the Gut Hormone Receptor for Glucagon-like Peptide 2 (GLP-2) by the GLP-2 Receptor Antagonist GLP-2(3-33) [NA]